Literature DB >> 15375749

Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brains.

J Guevara1, H Dilhuydy, B Espinosa, A Delacourte, R Quirion, R Mena, Y Joanette, E Zenteno, Y Robitaille.   

Abstract

Alzheimer's disease (AD) is a pathological process characterized by neuron degeneration and, as recently suggested, brain plasticity. In this work, we compared the reactive plasticity in AD brains associated to O-glycosydically linked glycans, recognized by lectins from Amaranthus leucocarpus (ALL) and Macrobrachium rosenbergii (MRL), and the tau neuritic degeneration. The neuritic degenerative process was evaluated by the quantification of aggregated neuritic structures. Lesions were determined using antibodies against hyperphosphorylated-tau (AD2), amyloid-beta, and synaptophysin. In these conditions, we classified and quantified three pathological structures associated to the neuritic degenerative process: 1) Amyloid-beta deposits (AbetaDs), 2) Classic neuritic plaques (NPs), and 3) Dystrophic neurites clusters (DNCs) lacking amyloid-beta deposits. Reactive plasticity structures were constituted by meganeuritic clusters (MCs) and peri-neuronal sprouting in neurons of the CA4 region of the hippocampus, immunoreactive to synaptophysin (exclusively in AD brains) and GAP-43. Besides, MCs were associated to sialylated O-glycosydically linked glycans as determined by positive labeling with ALL and MRL. Considering that these lectins are specific for the synaptic sprouting process in AD, our results suggest the co-occurrence of of several areas of reactive plasticity and neuron degeneration in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15375749     DOI: 10.14670/HH-19.1075

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  5 in total

Review 1.  Commentary: is Alzheimer's disease uniquely human?

Authors:  Caleb E Finch; Steven N Austad
Journal:  Neurobiol Aging       Date:  2014-10-23       Impact factor: 4.673

Review 2.  Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice.

Authors:  James H Park; Stephen M Strittmatter
Journal:  Curr Alzheimer Res       Date:  2007-12       Impact factor: 3.498

3.  Experimental microembolism induces localized neuritic pathology in guinea pig cerebrum.

Authors:  Jian-Ming Li; Yan Cai; Fei Liu; La Yang; Xia Hu; Peter R Patrylo; Huaibin Cai; Xue-Gang Luo; Dong Xiao; Xiao-Xin Yan
Journal:  Oncotarget       Date:  2015-05-10

Review 4.  Early Stage Glycosylation Biomarkers in Alzheimer's Disease.

Authors:  Patricia Regan; Paula L McClean; Thomas Smyth; Margaret Doherty
Journal:  Medicines (Basel)       Date:  2019-09-03

Review 5.  Defining the earliest pathological changes of Alzheimer's disease.

Authors:  James C Vickers; Stan Mitew; Adele Woodhouse; Carmen M Fernandez-Martos; Mathew T Kirkcaldie; Alison J Canty; Graeme H McCormack; Anna E King
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.